Chung Tsai - Alibaba Health Non-Executive Director
| TWY Stock | EUR 0.38 0.02 5.00% |
Director
Mr. Tsai Chung is a NonExecutive Director of the Company. He joined Alibaba Group in 1999 as a member of the Alibaba founding team and has served as the executive vice chairman of Alibaba Holding since May 2013. Mr. Tsai previously served as Alibaba Holdings chief financial officer and was a member of Alibaba Holdings board of directors since its formation. From 1995 to 1999, Mr. Tsai worked in Hong Kong with Investor AB, the main investment vehicle of Swedens Wallenberg family, where he was responsible for Asian private equity investments. Prior to that, he was vice president and general counsel of Rosecliff, Inc., a management buyout firm based in New York. From 1990 to 1993, Mr. Tsai was an associate attorney in the tax group of Sullivan Cromwell LLP, a New Yorkbased international law firm. Mr. Tsai serves on the boards of directors of several of Alibaba Groups investee companies and is currently also a director of Momo, Inc., the shares of which are listed on NASDAQ since 2015.
| Age | 52 |
| Tenure | 9 years |
| Phone | 852 2583 9333 |
| Web | https://www.alihealth.cn |
Alibaba Health Management Efficiency
The company has return on total asset (ROA) of (0.0168) % which means that it has lost $0.0168 on every $100 spent on assets. This is way below average. Alibaba Health's management efficiency ratios could be used to measure how well Alibaba Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Mary Jordan | Superior Plus Corp | 58 | |
| Marvin Schlanger | Sugi Holdings CoLtd | 69 | |
| Richard Gochnauer | Sugi Holdings CoLtd | 68 | |
| Theodore Dosch | Sugi Holdings CoLtd | 58 | |
| Patrick Gottschalk | Superior Plus Corp | 54 | |
| David Smith | Superior Plus Corp | 59 | |
| Walentin Mirosh | Superior Plus Corp | 71 | |
| Anne Pol | Sugi Holdings CoLtd | 70 | |
| James Stallings | Sugi Holdings CoLtd | 62 | |
| Shawn Puccio | Sugi Holdings CoLtd | 51 | |
| Robert Engbloom | Superior Plus Corp | 64 | |
| Daniel Cronin | Intel | N/A | |
| Alan Harris | Sugi Holdings CoLtd | 64 | |
| Randall Findlay | Superior Plus Corp | 67 | |
| Douglas Harrison | Superior Plus Corp | 58 | |
| Ernest Jones | Sugi Holdings CoLtd | 69 | |
| Roger Vincent | Sugi Holdings CoLtd | 70 | |
| Frank Hermance | Sugi Holdings CoLtd | 68 | |
| Eugene Bissell | Superior Plus Corp | 64 | |
| William Ruthrauff | Sugi Holdings CoLtd | N/A | |
| Catherine Best | Superior Plus Corp | 64 | |
Management Performance
| Return On Equity | 0.0088 | |||
| Return On Asset | -0.0168 |
Alibaba Health Infor Leadership Team
Elected by the shareholders, the Alibaba Health's board of directors comprises two types of representatives: Alibaba Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alibaba. The board's role is to monitor Alibaba Health's management team and ensure that shareholders' interests are well served. Alibaba Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alibaba Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yanwu Tu, CFO Director | ||
| Aishan Lew, Company Secretary | ||
| Yi Huang, Non-Executive Independent Director | ||
| Xiao Chen, Executive Vice Chairman of the Board | ||
| Aizhu Huang, Non-Executive Director | ||
| Shunyan Zhu, Chairman CEO | ||
| Yu Zhang, Non-Executive Director | ||
| Chun Kwong, Financial Controller | ||
| Kin Au, Company Secretary | ||
| Xuan Yan, Non-Executive Independent Director | ||
| Lei Wang, CEO, Executive Director | ||
| Chung Tsai, Non-Executive Director | ||
| Ka Chun, Company Sec | ||
| Hong Xu, Non-Executive Director | ||
| Yongming Wu, Non-Executive Chairman of the Board | ||
| Difan Shen, CEO, Executive Director | ||
| Kai Kang, Non-Executive Director | ||
| Tong Luo, Non-Executive Independent Director | ||
| Qiang Wang, Executive Director | ||
| On King, Non-Executive Independent Director | ||
| Chun Yan, Company Sec |
Alibaba Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Alibaba Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0088 | |||
| Return On Asset | -0.0168 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 14.05 B | |||
| Shares Outstanding | 13.52 B | |||
| Shares Owned By Insiders | 64.61 % | |||
| Shares Owned By Institutions | 11.01 % | |||
| Price To Book | 7.98 X | |||
| Price To Sales | 0.56 X |
Currently Active Assets on Macroaxis
| LAAC | Lithium Americas Corp | |
| F | Ford Motor | |
| CHPT | ChargePoint Holdings | |
| AXL | American Axle Manufacturing | |
| ICLN | iShares Global Clean |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Alibaba Health Information. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Alibaba Stock analysis
When running Alibaba Health's price analysis, check to measure Alibaba Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alibaba Health is operating at the current time. Most of Alibaba Health's value examination focuses on studying past and present price action to predict the probability of Alibaba Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alibaba Health's price. Additionally, you may evaluate how the addition of Alibaba Health to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |